Abstract: High dietary fructose intake causes a metabolic disorder and augments the risk of chronic kidney disease most likely due to oxidative stress. Probiotics could have antioxidant, antiinflammatory and immunoregulatory properties. The present study examined the influence of Lactobacillus helveticus and Lactobacillus plantarum supplementation on dietary fructose-induced metabolic changes and renal antioxidant/oxidant status of rats. Male Wistar rats were divided into four groups as follows: control; fructose; fructose plus L. helveticus; fructose plus L. plantarum. Fructose was given to the rats as a 20% solution in drinking water for 15 weeks. The probiotic supplementation was applied by gastric gavage once a day for six weeks. Several metabolic parameters in the plasma, gene and protein expressions of the main antioxidant enzymes in renal tissues of rats were measured. Dietary fructose-induced elevations in plasma insulin, triglyceride, VLDL, creatinine as well as renal urea levels were alleviated after treatment with L. helveticus and L. plantarum. Moreover, L. helveticus and L. plantarum supplementation recovered the changes in renal protein expression level of SOD1, SOD2 and CAT. In conclusion, supplementation with L. helveticus and L. plantarum has an improving effect on specific metabolic parameters and renal antioxidative enzymes in a fructose-induced metabolic disorder.
INTRODUCTION
Excess sugar intake, especially of fructose, has been shown to induce metabolic syndrome and kidney diseases via several molecular mechanisms, including activation of inflammatory processes and generation of oxidative stress [1, 2] . We previously described the upregulation of the inflammatory pathway and induction of the superoxide-producing system in various tissues with high dietary fructose intake [3] [4] [5] [6] [7] [8] [9] . Development of a proinflammatory condition, as manifested by nuclear factor-kappa B (NF-κB) activation, high expression of tumor necrosis factor-α (TNF-α), inducible nitric oxide synthase (iNOS) and interleukin-6 (IL-6), was demonstrated in the renal tissue of high-fructose-fed rats [10] . Furthermore, oxidative stress, as evidenced by decreased antioxidant enzyme activities and glutathione levels and increased malondialdehyde (MDA) contents in kidney tissues was shown in high-fructose-fed rats [11] [12] [13] [14] . Fructose-induced uric acid generation is proposed to lead to increased mitochondrial oxidative stress, endothelial dysfunction and maladaptive immune and inflammatory responses [15, 16] .
Probiotics are currently defined as nonpathogenic microorganisms and have been reported to improve metabolic diseases such as obesity and diabetes through modulation of intestinal microorganisms [17, 18] . Their beneficial health effects could be attributed to their antiinflammatory and immunoregulatory properties [19] . Some probiotic strains were shown to induce significant antioxidant activity through action on superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) [20] . Lactic acid bacterial strains, which are the principal representatives of probiotics in both food and pharmaceutical forms, have been shown to ameliorate metabolic diseases by increasing insulin sensitivity, reducing inflammatory reactions and oxidative stress [18, 21] . Supplementation with Lactobacillus plantarum along with a high-fat fructose diet in rats was shown to improve metabolic dysfunction by modulating blood proinflammatory cytokines, IL-1β, IL-6 and TNF-α, as well as the antioxidant enzymes, SOD, CAT and GPx [22] . The combination of L. curvatus and L. plantarum in high-fructose-fed rats lowered plasma glucose, insulin, triglyceride and oxidative stress, and also suppressed hepatic lipogenesis via downregulation of sterol regulatory element-binding transcription factor 1 (SREBP1) and fatty acid synthase (FAS) mRNA levels [23] . Knowledge of the influence of probiotic treatment on high-fructose-induced metabolic syndrome is limited. Therefore, in the present study, an attempt was made to investigate whether supplementation with L. helveticus and L. plantarum improves metabolic parameters and the renal antioxidant/oxidant status of fructose-fed rats.
MATERIALS AND METHODS

Chemicals
Chemicals were purchased from the Sigma Chemical Co. (St. Louis, MO) unless otherwise stated. Fructose was obtained from Danisco Sweeteners OY (Finland). L. helveticus and L. plantarum strains were obtained from Chr. Hansen (Denmark; ATCC: 15009 and ATCC: 14917 respectively) and grown in our laboratory.
Animals and diets
All protocols for animal usage were approved by the Ethical Animal Research Committee of Afyon Kocatepe University (Akuhadyek-49533702). Three-week-old male Wistar rats were housed in temperature-and humidity-controlled rooms (at 20-22°C and 40-60% humidity), with a 12-h light-dark cycle. The animals were fed with a standard rodent chow diet composed of 62% starch, 23% protein, 4% fat, 7% cellulose, standard vitamins and salt. At the end of the acclimation for one week, the rats were randomly divided into four groups, designated as Control; Fructose (Fruc); Fructose+L. helveticus (Fruc+LH) and Fructose+L. plantarum (Fruc+LP). Fructose was given to the rats as a 20% solution (w/v) in drinking water for 15 weeks. L. helveticus and L. plantarum (1x10 9 CFU per 100 g of body weight of animal) in 2 mL of saline were given by gastric gavage once a day during the final six weeks. The control and fructose groups were administered the same volume of saline by gavage for the same period. Body weights, food, and fluid intake were recorded weekly during the follow-up period. At the end of the follow-up period, the rats were anesthetized with a mixture of ketamine-xylazine (100 and 10 mg/ kg, respectively, i.p.) and blood samples were rapidly collected via cardiac puncture. The kidneys of rats were blotted dry, weighed, frozen in liquid nitrogen and stored at -85°C.
Preparation of L. helveticus and L. plantarum
L. helveticus and L. plantarum were cultured in de Man, Rogosa and Sharpe broth (MRS; Oxoid; Unipath Ltd., Basingstoke, Hampshire, England) at 30°C in a rotary shaker at 150 rpm. Stock cultures were stored at -80°C in MRS broth containing 20% (v/v) glycerol. Erlenmeyer flasks containing 20 mL of MRS were inoculated with 1.5 mL of glycerol stock culture and the cultures were incubated at 35°C±1°C in a rotary shaker at 150 rpm and grown to an optical density of 1.0 at 600 nm (cell density corresponding to 1x10 8 CFU/mL). The culture was divided into 10 mL tubes (1x10 9 CFU) and the cells were harvested at 5000 x g for 5 min at 4°C. The cell pellets were washed with isotonic saline solution and lyophilized under a freeze drier.
Measurement of metabolic parameters in plasma and renal tissue
Cardiac blood samples of non-fasted rats were immediately centrifuged at 10000 x g and 4°C for 30 min. Kidney samples were homogenized in 0.1 M phosphate buffer 1:10 (w/v), pH 7.4, and 24000 cycles/min (Ultra Turrax, IKA Works Inc., USA), and ultrasonicated at 20000 cycles/s for 1 min (Dr. Hielscher, Germany). Homogenates were centrifuged at 10000 x g and 4°C for 15 min, and the supernatants were collected. All the samples were stored at -85°C until analysis. Plasma triglyceride, very low-density lipoprotein (VLDL), highdensity lipoprotein (HDL) and total cholesterol levels were determined by standard enzymatic techniques. Insulin (Elabscience, USA), creatinine, urea, uric acid, albumin and total protein levels (Biolabo, France) were assessed using enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturers' instructions. Glucose levels were measured using a glucometer (Roche Diagnostics, USA) in blood collected from the tail veins of rats. MDA levels were measured with a TBARS assay kit (Cayman Chemical, USA).
Determination of sod1, sod2, cat, and gpx gene expressions by real-time polymerase chain reaction (qRT-PCR)
Total RNAs were isolated from kidney tissue using RNeasy total RNA isolation kit (Qiagen, Venlo, Netherlands) as described in the manufacturer's protocol. After isolation, the amount and the quality of the total RNA was determined by spectrophotometry and agarose gel electrophoresis. One µg of total RNA was reverse-transcribed to cDNA using a commercial first strand cDNA synthesis kit (Thermo Scientific, USA). Expression levels of sod1, sod2, cat, and gpx were determined by qRT-PCR (LightCycler480 II, Roche, Basel, Switzerland). One μL of cDNA, 5 μL 2X SYBR Green Master mix (Roche FastStart Universal SYBR Green Master Mix) and 2 μL primer pairs (sod1-F: GCAGAAGGCAAGCGGTGAAC; sod1-R: TAGCAG-GACAGCAGATGAGT; sod2-F: GCACATTAACGCG-CAGATCA; sod2-R: AGCCTCCAGCAACTCTCCTT; cat-F: GCGAATGGAGAGGCAGTGTAC; cat-R: GAGTGACGTTGTCTTCATTAGCACTG; gpx-F: CTCTCCGCGGTGGCACAGT; gpx-R: CCACCAC-CGGGTCGGACATAC; gapdh-F: TGATGACAT-CAAGAAGGTGGTGAAG; gapdh-R: TCCTTGGAG-GCCATGTGGGCCAT) were mixed and qRT-PCR was performed as follows; initial denaturation at 95°C for 10 min, denaturation at 95°C for 10 s, annealing at 58°C for 15 s, extension at 72°C for 15 s, with 40 repeated thermal cycles measuring the green fluorescence at the end of each extension step. All reactions were performed in triplicate and the specificity of PCR products was confirmed by melt analysis. The relative expression of genes to internal control glyceraldehyde 3-phosphate dehydrogenase (gapdh) was calculated with the quantification tool provided by LightCycler® 480 SW 1.5.1 software.
Immunoblot analysis of antioxidant enzymes, SOD1, SOD2, CAT and GPx
For determination of SOD1, SOD2, CAT and GPx protein contents, kidney tissue was homogenized in 2-fold volumes of homogenization medium (50 mM Tris, 150 mM NaCl, 5 mM EDTA, 1 % (w/w) Triton X-100, 0.26% (w/v) sodium deoxycholate, 50 mM sodium fluoride, 0.1 mM sodium orthovanadate and 0.2 mM phenylmethylsulfonyl fluoride (PMSF)) with a Tissue Ruptor TM (Qiagen, Netherlands) homogenizer. The homogenates were centrifuged at 1500 x g for 10 min at 4ºC. After the removal of the supernatants, the protein concentrations were determined by the Lowry method [24] . Ten to 50 µg of total proteins were separated by SDS-PAGE and transferred on to PVDF membranes using a semi-dry electroblotting apparatus (TransBlot Turbo, BioRad, Germany). Blotted membranes were blocked with 5% (w/v) nonfat dried milk and incubated with primary antibodies for SOD1 (Anti-SOD1 Sheep IgG, Calbiochem-574597, 1:5,000), SOD2 (Anti-SOD2 Rabbit IgG, Santa Cruz; sc:30080, 1:100), CAT (Anti-CAT Rabbit IgG, Abcam, ab:6731,1:6,000), GPx (Anti-GPx Rabbit IgG, Santa Cruz, sc:30147,1:100) for 2 h at room temperature or overnight at 4ºC. As an internal control, GAPDH proteins were also labeled with anti-GAPDH Rabbit IgG (Santa Cruz, sc:25778, 1:2,000). Horseradish peroxidase-conjugated secondary antibody (Santa Cruz, sc:2030 or sc:2770, 1:10,000) was incubated for 1 h, and the blots were incubated in Clarity TM Western ECL (Bio-Rad Laboratories, Hercules CA, USA) substrate solution. Images of the blots were obtained using the ChemiDoc TM MP Chemiluminescence detection system (Bio-Rad Laboratories, Hercules CA, USA) equipped with a CCD camera. The relative expression of proteins with respect to GAPDH was calculated using ImageLab5.2 software.
Statistical analysis
All data are presented as the mean±standard error of the mean; n is the number of rats. Statistical comparisons were performed using unpaired Student's t-test or one-way ANOVA followed by the Tukey post hoc test. P values smaller than 0.05 were considered as statistically significant.
RESULTS
The effects of dietary fructose and supplementation with L. helveticus and L. plantarum on body weight, caloric intake and kidney weight
As shown in Table 1 , the high-dietary-fructose intervention did not change the final body weights of rats despite the increase in total caloric intake. There was a trend toward an increase in final body weight in Fruc+LH group when compared to the fructose group, but the differences were not significant. Besides, no significant change was found in the final body weights of rats between Fruc and Fruc+LP groups. The total caloric intakes were not changed after supplementation with L. helveticus and L. plantarum when compared to the fructose group. Moreover, the right and left kidney absolute weights, as well as the ratio of right or left kidney weights to the body weight were not significantly altered between the groups ( Table 1 ).
The effects of dietary fructose and supplementation with L. helveticus and L. plantarum on metabolic and biochemical parameters in plasma and kidney As shown in Table 2 , high dietary fructose increased the plasma glucose and insulin levels as compared to control group. The probiotic supplementation did not Plasma MDA levels, but not the renal concentration, increased in rats that were fed with fructose. Moreover, supplementation with L. helveticus and L. plantarum did not modulate the MDA levels. Dietary fructose also increased the plasma creatinine levels, and conversely, L. helveticus and L. plantarum supplementation reduced the creatinine levels to the control value. Significant changes in plasma urea, uric acid, albumin and total protein contents were determined between groups: plasma uric acid levels in the L. helveticus-treated group were decreased. High-fructose intake increased renal urea concentration, which was decreased by L. helveticus and L. plantarum supplementation. Additionally, L. plantarum treatment significantly decreased the renal uric acid levels as compared to the fructose group.
The effects of dietary fructose and supplementation with L. helveticus and L. plantarum on SOD1, SOD2, CAT and GPx gene and protein expression
Relative changes in antioxidant enzyme gene and protein expression levels in kidney tissue were measured by qRT-PCR and Western blot analysis, respectively. The results show the suppression of sod1 and sod2 mRNA expression in fructose-fed rats. However, treatments with L. helveticus and L. plantarum did not alter sod1 expression, but L. plantarum significantly increased sod2 mRNA levels ( Fig. 1A and 1B) . Moreover, highfructose intake significantly increased cat mRNA expressions but not gpx levels. Supplementation of L. helveticus and L. plantarum did not modulate the cat and gpx gene expressions significantly (Fig. 1C and D) . Fig. 2A and B, SOD1 and SOD2 protein expression was decreased in fructose-fed rats. Supplementation with L. helveticus and L. plantarum increased both SOD1 and SOD2 protein expression ( Fig. 2A and B) . Parallel with the gene expression pattern, CAT protein expression was increased in the fructose group (Fig. 2C ) but significantly decreased after treatments with L. helveticus and L. plantarum. No change was observed in GPx levels among all examined groups (Fig. 2D) .
DISCUSSION
Fructose is commonly used as an industrial sweetener and is excessively consumed in the regular human diet. Overconsumption of fructose has been proposed as a risk factor for the metabolic syndrome, manifesting in dysfunctional adipose, liver, kidney, intestine and cardiovascular tissues [25] . One of the leading driving forces for the fructose-induced disturbances is the oxidative stress arising from an imbalance between the prooxidant and antioxidant systems [26] . This study demonstrated some favorable influences of probiotic supplementation with L. helveticus and L. plantarum on the metabolic parameters and renal antioxidant/ oxidant status of rats maintained on a high-fructose diet.
Probiotics have emerged as a therapeutic potential for metabolic syndrome, especially in the high-fat diet model [27] [28] [29] . Data describing the influence of probiotic treatment on high-fructose-induced metabolic syndrome is limited [22, 30] . Therefore, we evaluated the effects of the supplementation of two commonly used probiotic microorganisms, L. helveticus and L. plantarum, on metabolic, plasma and renal antioxidant/oxidant markers. The findings presented herein demonstrated hyperinsulinemia and hypertriglyceridemia with high-fructose intake, which is in accordance with our previous studies [3, 4, 6, 9] . There were no significant alteration in the body weights and the ratio of renal weights to body weights in rats fed with high-fructose diet. L. helveticus and L. plantarum supplementation diminished the increase in plasma triglyceride. Moreover, L. plantarum treatment restored the elevated plasma insulin levels. The plasma glucose-and lipid-lowering effects of L. plantarum were previously reported in high-fat-or high-fructose-induced metabolic disorders [22, 27, 28, 30] . Moreover, the consumption of a combination of L. curvatus and L. plantarum probiotic strains was shown to reduce plasma triglyceride levels in hypertriglyceridemic subjects [31] . Administration of the probiotic L. kefiri to mice fed with a fructoserich diet prevented the increase in plasma triglycerides and leptin [32] . An early sign of nephropathy is an increase in serum creatinine, which is associated with the progression of renal damage [33] . Serum urea and uric acid levels are also essential parameters of renal functions. Fructose-induced hyperglycemia may impair renal functions and increase plasma creatinine, urea and uric acid levels as well as oxidative stress [15, 34] . In this study, a significant increase in the levels of plasma creatinine and renal urea could be taken as a reflection of a fructose-induced renal disorder. The correction of these abnormalities by L. helveticus and L. plantarum supplementation could be valuable in prevention of the disease. Previously, it has been demonstrated that probiotic therapy with L. plantarum strains improves urinary oxalate, calcium, uric acid, creatinine and serum uric acid levels in rats with increased renal calcium oxalate deposition [35] . A diet rich in fructose can lead to the induction of marked oxidative stress and mitochondrial dysfunction [36] . Oxidative stress arising from a high-fructose diet has been shown to suppress antioxidant enzymes in different tissues [37] [38] [39] [40] [41] . Renal SOD, CAT and GPx levels were reduced in rats with fructose-induced metabolic syndrome [12, 42, 43] . However, contradictory results have demonstrated the upregulation of catalase in hepatic tissues [44] . Besides, the enzymes in the liver or kidney tissues were also reported to be unchanged in similar animal models [45] . Recently, we demonstrated significant suppression of both CAT, GPx and SOD gene and protein expression in the renal tissues of diabetic rats [46] . The suppression was attributed to a moderate increase in tissue oxidative biomarkers. In this study, we demonstrated alterations of oxidative stress markers in plasma and reduction in renal SOD1 and SOD2 gene and protein expressions. These results indicate the presence of oxidative stress in fructose-fed rats. On the contrary, both CAT gene and protein expression were upregulated in renal tissue of fructose-fed rats. Such discrepancy might result from differences in intracellular locations since most of the CAT is present in peroxisomes which could prevent it from participating in primary oxidation reactions arising from excessive mitochondrial input through the electron transport systems [47] . Upregulation of CAT could be seen as an adaptation process to the moderate increase in oxidative stress biomarkers in peroxisomes.
Recent studies proposed that probiotics can stimulate the antioxidant systems of the host and augment the activities of antioxidant enzymes [20] . Supplementation with probiotics and vitamin C increased the activity of antioxidant enzymes in the serum, brain and kidneys in type 1 diabetic rats [48] . Administration of L. casei with inulin to healthy volunteers resulted in a significant increase in plasma CAT activity [49] and in a significant decrease in plasma MDA and oxidized glutathione concentrations and increased free thiol and glutathione contents [50] . Moreover, probiotics provided significant protection against mercury-induced toxicity by preventing alterations in the levels of GPx and SOD [51] . In another study, upregulation of serum SOD, GPx and hepatic CAT activities with dietary L. fermentum was demonstrated [52] . Moreover, yeast probiotic supplementation increased the body weights and serum antioxidant enzyme activities in chicks [53] . In line with these findings, a study conducted with humans demonstrated increased SOD and GPx activities in erythrocytes of diabetic patients supplemented with L. acidophilus and Bifidobacterium lactis [54] . In our study, treatment with L. helveticus and L. plantarum strains did not affect the gene expression patterns of sod1 and cat, however, L. plantarum upregulated sod2. In contrast to gene expression levels, the changes in protein expression levels of these enzymes were normalized with both probiotics. These results suggested that L. helveticus and L. plantarum might have a positive influence on renal antioxidant capacity in the dietary fructose-induced metabolic disorder.
In conclusion, supplementation with L. helveticus and L. plantarum has an improving effect on specific metabolic parameters and renal antioxidative enzymes in a fructose-induced metabolic disorder.
